Новости | Магазин | Журналы | Контакты | Правила | Доставка | |
Вход Регистрация |
Ключевые слова:
Литература:
The aim of this study was the estimation of advantages of the new contrast agent with double gadolinium concentration (Gadovist 1.0) in comparison with 0,5M contrast agent (Magnevist) in examinations of patients with multiple sclerosis “SIGNA Contour”, (GE) MRI unit. As the result of the performed study a higher ability of Gadovist 1.0 was proved for the visualization of active demyelinating lesions in a comparison with Magnevist.
Keywords: